NovoCure NVCR Enterprise value

Enterprise value at other companies

Boston ScientificBSX

$141.04B-1.0%

MedtronicMDT

$131.22B-3.2%

Nuvation BioNUVB

$1.73B+241%

Iovance Biotherapeutics, Inc.IOVA

$1.79B+227%

Tango TherapeuticsTNGX

$2.86B+2,204%

Gyre Therapeutics, Inc.GYRE

$694.84M+6.1%

FAQ

What is NovoCure's enterprise value?

NovoCure (NVCR) reported enterprise value of $1.7B in Q2 2026.

How has NovoCure's enterprise value changed year-over-year?

NovoCure's enterprise value decreased by 5.0% year-over-year, from $1.79B to $1.7B.

What is the long-term trend for NovoCure's enterprise value?

Over 5 years (2020 to 2025), NovoCure's enterprise value has grown at a -40.1% compound annual growth rate (CAGR), from $18.18B to $1.41B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.